Loading...

BeOne Medicines Ltd.

ONCNASDAQ
Healthcare
Medical - Pharmaceuticals
$244.32
$-0.84(-0.34%)

BeOne Medicines Ltd. ONC Peers

See (ONC) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ONC$244.32-0.34%24.2B-67.23-$3.63N/A
INSM$98.24+0.64%18.7B-16.55-$5.94N/A
WBA$11.49+0.00%9.9B-1.58-$7.29+4.36%
HROWL$25.51-0.06%1.2BN/AN/AN/A
HROWM$26.58+0.00%1.1BN/AN/A+11.16%
LFMDP$24.25+0.00%1.1B-10.75-$2.26N/A
LFMD$12.93-1.52%587M-39.14-$0.33N/A
HITI$2.34+1.74%190M-26.06-$0.09N/A
PETS$3.37+3.06%70.2M340.00$0.01N/A
YI$7.34+3.53%63.6M-3.38-$2.17N/A
Showing 1 to 10 of 21 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ONC vs INSM Comparison

ONC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ONC stands at 24.2B. In comparison, INSM has a market cap of 18.7B. Regarding current trading prices, ONC is priced at $244.32, while INSM trades at $98.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ONC currently has a P/E ratio of -67.23, whereas INSM's P/E ratio is -16.55. In terms of profitability, ONC's ROE is -0.12%, compared to INSM's ROE of -4.47%. Regarding short-term risk, ONC is more volatile compared to INSM. This indicates potentially higher risk in terms of short-term price fluctuations for ONC.

Stock Price Comparison

Loading...

Frequently Asked Questions

;